Collagen Solutions (LON:COS) announced its earnings results on Friday. The company reported GBX (0.76) (($0.01)) earnings per share (EPS) for the quarter, Digital Look Earnings reports.
Shares of COS opened at GBX 2.75 ($0.03) on Friday. The company has a current ratio of 2.32, a quick ratio of 2.16 and a debt-to-equity ratio of 9.51. The firm has a market cap of $12.20 million and a PE ratio of -6.88. The company’s 50 day simple moving average is GBX 3 and its 200-day simple moving average is GBX 2.59. Collagen Solutions has a 12-month low of GBX 0.03 ($0.00) and a 12-month high of GBX 4.20 ($0.05).
About Collagen Solutions
Collagen Solutions plc sources, develops, manufactures, and supplies medical grade collagen components and biomaterials for use in research, regenerative medicines, medical devices, and in-vitro diagnostics in Europe, the Middle East, Africa, North America, and Asia. It offers collagen soluble collagen, collagen powders, fibrillars, collagen gels, freeze dried collagen, and other products for use in orthopaedic, sports medicine, dental, wound care, cardiovascular, general, plastic, and reconstructive surgeries, as well as 3D cell culture research; Bovine Pericardium is used in bio-prosthetic heart valves, dural closures, bone and dental membranes, and surgical buttressing applications; and BSE-free bovine biomaterials.
Further Reading: Asset Allocation, Balancing Your Investments
Receive News & Ratings for Collagen Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Collagen Solutions and related companies with MarketBeat.com's FREE daily email newsletter.